$INO Recent Headlines Monday's biggest gaining a
Post# of 44956
Posted On: 01/09/2014 10:55:04 PM
$INO Recent Headlines
Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein
Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com
Inovio Pharmaceuticals (INO) Soars: Stock Zooms 20.2% - Tale of the Tape 8:51 a.m. Dec. 27, 2013 - Zacks.com
Arena, Inovio rally after positive mention 10:57 a.m. Dec. 26, 2013 - Seeking Alpha
3 Biotechs That Could Double In 2014 8:48 a.m. Dec. 26, 2013 - Seeking Alpha
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Buy Inovio Due To Insider Interest And Upcoming Trial Results 8:21 a.m. Dec. 19, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem 9:14 a.m. Dec. 4, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Insider Interest, Positive Trial Data And Upcoming Catalysts, Everything Is Going For In 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Inovio Pharma jumps on MERS vaccine news 8:22 a.m. Nov. 20, 2013 - Seeking Alpha
Inovio Pharmaceutical's DNA Vaccine for MERS Virus Shows Promising Results in Preclinical Trial 4:44 a.m. Nov. 20, 2013 - benzinga.com
Insider Trading Alert - INO, PSMT, CBI, BRS And EHTH Traded By Insiders 12:02 p.m. Nov. 15, 2013 - TheStreet.com
Treating Melanoma: Only The Best Shall Survive 3:31 p.m. Nov. 13, 2013 - Seeking Alpha
Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire
Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. 8:27 a.m. Oct. 4, 2013 - PR Newswire
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum 3:00 a.m. Oct. 1, 2013 - PR Newswire
Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies 4:12 a.m. Sept. 24, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles 3:00 a.m. Sept. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche 3:10 a.m. Sept. 10, 2013 - PR Newswire
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products 3:00 a.m. Sept. 10, 2013 - PR Newswire
Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein
Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com
Inovio Pharmaceuticals (INO) Soars: Stock Zooms 20.2% - Tale of the Tape 8:51 a.m. Dec. 27, 2013 - Zacks.com
Arena, Inovio rally after positive mention 10:57 a.m. Dec. 26, 2013 - Seeking Alpha
3 Biotechs That Could Double In 2014 8:48 a.m. Dec. 26, 2013 - Seeking Alpha
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Buy Inovio Due To Insider Interest And Upcoming Trial Results 8:21 a.m. Dec. 19, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem 9:14 a.m. Dec. 4, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Insider Interest, Positive Trial Data And Upcoming Catalysts, Everything Is Going For In 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Inovio Pharma jumps on MERS vaccine news 8:22 a.m. Nov. 20, 2013 - Seeking Alpha
Inovio Pharmaceutical's DNA Vaccine for MERS Virus Shows Promising Results in Preclinical Trial 4:44 a.m. Nov. 20, 2013 - benzinga.com
Insider Trading Alert - INO, PSMT, CBI, BRS And EHTH Traded By Insiders 12:02 p.m. Nov. 15, 2013 - TheStreet.com
Treating Melanoma: Only The Best Shall Survive 3:31 p.m. Nov. 13, 2013 - Seeking Alpha
Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire
Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. 8:27 a.m. Oct. 4, 2013 - PR Newswire
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum 3:00 a.m. Oct. 1, 2013 - PR Newswire
Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies 4:12 a.m. Sept. 24, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles 3:00 a.m. Sept. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche 3:10 a.m. Sept. 10, 2013 - PR Newswire
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products 3:00 a.m. Sept. 10, 2013 - PR Newswire
(0)
(0)